|
DGAP-News: GEA Group Aktiengesellschaft
/ Key word(s): Sustainability/Real Estate
Factory of the Future GEA invests EUR 70 million in pharma technology center in Germany
Düsseldorf (Germany), September 2, 2022 - GEA is investing EUR 70 million in the construction of a new pharmaceutical technology center for freeze dryers in Elsdorf in the German state of North Rhine-Westphalia. Spread across some 40,000 m², the new facility, which is scheduled for completion by 2024, will stimulate better innovation opportunities and further growth in the attractive freeze-drying pharmaceuticals market. This process is essential to manufacturing a wide variety of injectable pharmaceutical products, such as vaccines. GEA is a longstanding leader in the global freeze-drying market. “With our Mission 26 strategy, we aim to spur our profitable growth by offering sustainable solutions for the food and pharmaceutical industries,” says CEO Stefan Klebert. “Given how the new pharmaceutical technology center will leverage GEA’s full potential in the growing pharmaceutical sector, this investment dovetails perfectly with Mission 26.” Since the current plant in Hürth, North Rhine-Westphalia, has reached its capacity limit, all areas, from development through design and production to assembly and services will relocate to the new site. Construction will get underway in 2023. All of the approximately 250 employees will relocate to the new nearby plant. "By building in Elsdorf, the GEA Group has sent a strong signal that it is a good place to do business. We are very pleased about this decision and hope that it will lead to further commercial land designations and commercial settlements. My thanks in particular go to the representatives of GEA, who have chosen Elsdorf, as well as to the urban development company and our business development department, who have jointly implemented the process," emphasizes Mayor Andreas Heller.
Elsdorf will be home to GEA’s second Factory of the Future Following the construction of the first newly designed site in Koszalin (Poland), which started production this year, the second "GEA Factory of the Future" is being built in Elsdorf. The concept is based on modular and digital production structures that ensure maximum flexibility while maintaining productivity, thus making a significant contribution to the growth strategy in the pharmaceutical sector. Construction work on the new site will adhere to the highest sustainability standards (e.g. dedicated power generation, carbon neutrality) and implement innovative new digital solutions at every link in the value chain. “Our Factory of the Future concept is instrumental to driving corporate growth and securing long-term competitiveness,” says COO Johannes Giloth. “Elsdorf will set new benchmarks for optimizing our global production network and its performance.”
Media Relations Anne Putz Peter-Müller-Str. 12, 40468 Düsseldorf, Germany Phone 00
About GEA GEA is one of the world's largest suppliers of systems and components to the food, beverage and pharmaceutical industries. The international technology group, founded in 1881, focuses on machinery and plants, as well as advanced process technology, components, and comprehensive services. With more than 18,000 employees working across five divisions and 62 countries, the group generated revenues of more than EUR 4.7 billion in fiscal year 2021. GEA plants, processes, components and services enhance the efficiency and sustainability of production processes across the globe. They contribute significantly to the reduction of CO2 emissions, plastic usage and food waste. In doing so, GEA makes a key contribution toward a sustainable future, in line with the company’s purpose: "Engineering for a better world". GEA is listed in the German MDAX and the STOXX® Europe 600 Index and is also among the companies comprising the DAX 50 ESG and MSCI Global Sustainability Indices. More information can be found online at gea.com.
Additional features: File:
02.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
| Language: | English |
| Company: | GEA Group Aktiengesellschaft |
| Peter-Müller-Straße 12 | |
| 40468 Düsseldorf | |
| Germany | |
| Phone: | +49 (0)211 9136-0 |
| Fax: | +49 (0)211 9136-31087 |
| E-mail: | |
| Internet: | |
| ISIN: | DE0006602006 |
| WKN: | 660200 |
| Indices: | MDAX |
| Listed: | Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Munich; Regulated Unofficial Market in Hanover, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1433897 |
| End of News | DGAP News Service |
|
|
1433897 02.09.2022 CET/CEST
